![]() ![]() ![]() In any case, the action by Peters and his colleagues is being seen as one of many unsettled issues in the Democrats’ $3.5 trillion budget reconciliation bill that would vastly expand the nation’s social and medical programs. Other groups point to a scaled-back alternative proposed by Peters they say will limit drug costs while keeping the industry able to pursue innovative research. Some patient advocacy groups and experts contend that the measure’s failure will continue to ensure the industry earns big profits while keeping drug costs too high. ![]() ![]() That measure is strongly opposed by the Pharmaceutical Research and Manufacturers of America (PhRMA) and Biocom California, a San Diego-based trade group that represents 1,400 life science companies across the state, who say it will choke off needed funding to recoup costs for developing new therapies.
0 Comments
Leave a Reply. |
Details
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |